|
|||||
|
|
The complement receptor 3 (CD11b/CD18) agonist Leukadherin‐1 suppresses human innate inflammatory signalling |
|
| Authors: | A. L. Roberts B. G. Fürnrohr T. J. Vyse B. Rhodes |
| Affiliation: | 1. Division of Genetics and Molecular Medicine and Division of Infection, Immunity and Inflammatory Disease, King's College London, London, UK;2. Division of Biological Chemistry, Innrain 80/IV, Medical University Innsbruck, Innsbruck, Austria;3. Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK |
| Abstract: | |
| Keywords: | complement receptor 3 innate immunity Leukadherin‐1 NK cells systemic lupus erythematosus |